Leptin regulates bone formation via the sympathetic nervous system

Cell

Volumn 111, Issue 3, 2002, Pages 305-317

  Takeda, Shu ^a   Elefteriou, Florent ^a   Levasseur, Regis ^a   Liu, Xiuyun ^a   Zhao, Liping ^d   Parker, Keith L ^d   Armstrong, Dawna ^a   Ducy, Patricia ^a,b,c   Karsenty, Gerard ^a,b  

^a One Baylor Plaza ^*  (United States)

^b Bone Disease Program of Texas   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LEPTIN; NEUROPEPTIDE;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MASS; CONTROLLED STUDY; HYPOTHALAMUS; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; WILD TYPE;

ANIMALIA;

EID: 0036847619     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)01049-8     Document Type: Article

References (47)

1. Adachi J.D., Bensen W.G., Hodsman A.B. Corticosteroid-induced osteoporosis. Semin. Arthritis Rheum. 22:1993;375-384.
2. Ahima R.S., Flier J.S. Leptin. Annu. Rev. Physiol. 62:2000;413-437.
3. Alaniz R.C., Thomas S.A., Perez-Melgosa M., Mueller K., Farr A.G., Palmiter R.D., Wilson C.B. Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc. Natl. Acad. Sci. USA. 96:1999;2274-2278.
4. Asnicar M.A., Smith D.P., Yang D.D., Heiman M.L., Fox N., Chen Y.F., Hsiung H.M., Koster A. Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology. 142:2001;4394-4400.
5. Ausubel F.M. Current Protocols in Molecular Biology. 1995;Wiley Interscience, New York.
6. Benovic J.L., Bouvier M., Caron M.G., Lefkowitz R.J. Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu. Rev. Cell Biol. 4:1988;405-428.
7. Bliziotes M., McLoughlin S., Gunness M., Fumagalli F., Jones S.R., Caron M.G. Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene. Bone. 26:2000;15-19.
8. Bray G.A., York D.A. The MONA LISA hypothesis in the time of leptin. Recent Prog. Horm. Res. 53:1998;95-117.
9. Cooper C., Melton L.J.I. Magnitude and impact of osteoporosis and fractures. Marcus R., Feldman D., Kelsey J. Osteoporosis. 1996;Academic Press, San Diego. 419-434.pp.
10. Corral D., Amling M., Priemel M., Loyer E., Fuchs S., Ducy P., Baron R., Karsenty G. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc. Natl. Acad. Sci. USA. 95:1998;13835-13840.
11. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., Cone R.D., Low M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480-484.
12. Debons A.F., Silver L., Cronkite E.P., Johnson H.A., Brecher G., Tenzer D., Schwartz I.L. Localization of gold in mouse brain in relation to gold thioglucose obesity. Am. J. Physiol. 4:1962;743-750.
13. DeFalco J., Tomishima M., Liu H., Zhao C., Cai X., Marth J.D., Enquist L., Friedman J.M. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science. 291:2001;2608-2613.
14. Dellovade T., Young M., Ross E.P., Henderson R., Caron K., Parker K., Tobet S.A. Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes. J. Comp. Neurol. 423:2000;579-589.
15. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1999;1025-1036.
16. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil T., Shen J., Vinson C., Rueger J.M., Karsenty G. Leptin inhibits bone formation through a hypothalamic relay. a central control of bone mass Cell. 100:2000;197-207.
17. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C., Flier J.S., Saper C.B., Elmquist J.K. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron. 23:1999;775-786.
18. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
19. Fei H., Okano H.J., Li C., Lee G.H., Zhao C., Darnell R., Friedman J.M. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA. 94:1997;7001-7005.
20. Felson D.T., Zhang Y., Hannan M.T., Anderson J.J. Effects of weight and body mass index on bone mineral density in men and women. the Framingham study J. Bone Miner. Res. 8:1993;567-573.
21. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
22. Gardella T.J., Juppner H. Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol. Metab. 12:2001;210-217.
23. Halaas J.L., Boozer C., Blair-West J., Fidahusein N., Denton D.A., Friedman J.M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA. 94:1997;8878-8883.
24. Harris R.B., Martin R.J. Specific depletion of body fat in parabiotic partners of tube-fed obese rats. Am. J. Physiol. 247:1984;R380-R386.
25. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D.et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
26. Ikeda Y., Luo X., Abbud R., Nilson J.H., Parker K.L. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol. Endocrinol. 9:1995;478-486.
27. Karst H., Karten Y.J., Reichardt H.M., de Kloet E.R., Schutz G., Joels M. Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers. Nat. Neurosci. 3:2000;977-978.
28. Kaufman J.M., Taelman P., Vermeulen A., Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J. Clin. Endocrinol. Metab. 74:1992;118-123.
29. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N.et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 393:1998;72-76.
30. Lu D., Willard D., Patel I.R., Kadwell S., Overton L., Kost T., Luther M., Chen W., Woychik R.P., Wilkison W.O.et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 371:1994;799-802.
31. Miller M.W., Duhl D.M., Vrieling H., Cordes S.P., Ollmann M.M., Winkes B.M., Barsh G.S. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7:1993;454-467.
32. Minkowitz B., Boskey A.L., Lane J.M., Pearlman H.S., Vigorita V.J. Effects of propranolol on bone metabolism in the rat. J. Orthop. Res. 9:1991;869-875.
33. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 164:1969;719-721.
34. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis H.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry. standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry committee J. Bone Miner. Res. 6:1987;595-610.
35. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., Schutz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 93:1998;531-541.
36. Riggs B.L., Khosla S., Melton III L.J. A unitary model for involutional osteoporosis. estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men J. Bone Miner. Res. 13:1998;763-773.
37. Rossert J., Eberspaecher H., de Crombrugghe B. Separate cis-acting DNA elements of the mouse Pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J. Cell Biol. 129:1995;1421-1432.
38. Ruffin M., Nicolaidis S. Electrical stimulation of the ventromedial hypothalamus enhances both fat utilization and metabolic rate that precede and parallel the inhibition of feeding behavior. Brain Res. 846:1999;23-29.
39. Satoh N., Ogawa Y., Katsuura G., Numata Y., Tsuji T., Hayase M., Ebihara K., Masuzaki H., Hosoda K., Yoshimasa Y., Nakao K. Sympathetic activation of leptin via the ventromedial hypothalamus. leptin-induced increase in catecholamine secretion Diabetes. 48:1999;1787-1793.
40. Scarpace P.J., Matheny M. Leptin induction of UCP1 gene expression is dependent on sympathetic innervation. Am. J. Physiol. 275:1998;E259-E264.
41. Schwartzman R.J. New treatments for reflex sympathetic dystrophy. N. Engl. J. Med. 343:2000;654-656.
42. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J.et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1995;1263-1271.
43. Thomas S.A., Marck B.T., Palmiter R.D., Matsumoto A.M. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J. Neurochem. 70:1998;2468-2476.
44. Tremollieres F.A., Pouilles J.M., Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women. a longitudinal study in 155 early postmenopausal women J. Clin. Endocrinol. Metab. 77:1993;683-686.
45. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20:1998;113-114.
46. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20:1998;111-112.
47. Young J.B., Landsberg L. The adrenal. Wilson J.D., Foster D.W., Kronenberg H., Larsen P.R. Williams Textbook of Endocrinology. 1998;W.B. Saunders Co, Philadelphia. 665-682.pp.